Australian scientists may have found the cure for cancer, the disease which kills millions of people each day.
A rare berry containing cancer-fighting compounds has been found in nature that begins to kill cancer cells immediately and it only grows in one place in the entire world; the rainforests of Tropical North Queensland, Australia.
From Underground Reporter:
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
This cancer-fighting blushwood berry, also known as Hylandia dockrillii, has been uncovered in a far northern part of Australia, known for its proximity to the Great Barrier Reef and over 70 national parks, in the rainforests of North Queensland. The phyto-active compounds in this berry, namely a molecule which scientists are calling EBC-46, are so potent that they’ve killed cancerous tumors in lab experiments in as few as seven days. Other cancers were eradicated within only 48 hours.
Elites Panic As Queen’s Death Threatens To Expose Pedophile Ring
WEF Anoint Charles ‘The Great Reset King’
WEF To Force Public To Wear ‘Brain Implants’ So the Elite Can Read Their Minds
Woody Harrelson Slams Big Pharma: 'The Last People You Should Trust With Your Health'
NASA Insider Confesses on Deathbed: I Filmed Fake Moon Landing in 1969
Disney’s ‘Little Demon’ Is Normalizing Satanism and Pedophilia for the Masses
Nostradamus Predicted 'Great Uprising' Against King Charles III
King Charles III Vows To Usher In ‘Great Reset’ Following Queen Elizabeth’s Death
Bill Gates’ Factory Breeding 30 Million Mosquitos Infected With ‘Infertility Bacteria’ Per Week
Numerous clinical trials have already shown promise for treating cancer in laboratory animals, including horses, rats, and dogs, and the first human trials on a drug made from blush berries may have kept one woman from having to undergo an amputation of her arm. In a shocking twenty minutes, she says the tumor, “went purple, then black, and within a couple days, the tumor just shriveled up and died.”
The compound causes no side effects, and works faster than almost anything doctors have ever seen. It works specifically on spot-melanomas, like skin cancer.
EBC-46 seems to trigger an immune response when injected into cancerous tumor sites. Our white blood cells then attack the tumor and shrink it so that the body can completely dispose of the cancerous cells which formed it.
Blushwood berries seem to be chock-full of this tumor-fighting compound. QIMR Berghofer Medical Research Institute in Queensland, Australia, recently conducted a study on the blushwood berry and found that in over 70 percent of cases, when the compound was used, cancerous tumors die.
Dr. Glen Boyle, who led the study, says, “There’s a compound in the seed — it’s a very, very complicated process to purify this compound and why it’s there in the first place, we don’t know.”
Boyle explains that the tree is “very, very picky” about where it will grow. He says, “It’s only on the Atherton Tablelands at the moment and they’re trying to expand that to different places of course because it’d be nice to be able to grow it on a farm somewhere.”
Though Dr. Boyle says the blushwood berry compound could be used to augment chemotherapy treatment, there is a possibility that the drug could help cure cancer simply through ingesting the fruit, itself, or applying it topically. No clinical evidence has yet proven the blushwood berry to work in its whole, natural form, but if the compound gained from its flesh is so effective, might not the fruit itself prove efficacious in healing non-metastatic cancers?
Blushwood berry compounds are thought to cut off the oxygen supply to cancer cells, allowing for the removal of tumors without any need for surgery, chemotherapy, or radiation therapy. No wonder an Australian woman was able to save her arm from an amputation.
Latest posts by Edmondo Burr (see all)
- Police Arrest Suspect In Supermarket Baby Food Poisoning - October 1, 2017
- Seoul Secures Data From Electromagnetic Interference By N Korea - September 30, 2017
- The ‘World’s First Internet War’ Has Begun: Julian Assange - September 30, 2017